LGC expands production of AccuPlex™ COVID-19 reference materials to support global diagnostic assay development efforts

News (ZH) - Expansion of COVID-19 reference materials to include high titer stocks that serve as a valuable tool for diagnostic manufacturers

Swift Biosciences and LGC partner on targeted sequencing assays for AgBio market

News (ZH) - LGC will be Swift’s exclusive worldwide partner for amplicon-based targeted sequencing assays for genotyping AgBio samples, including crop species and animals

LGC and customers expediting coronavirus diagnostic solutions

News (ZH) - Working closely with customers to ensure mission-critical oligo chemistries, controls and components for detection kits are available where and when necessary

LGC employing AccuPlex™ technology to develop quality control solutions in response to the coronavirus global health emergency

News (ZH) - Control material being produced in collaboration with several diagnostic manufacturers to support development, evaluation, and validation of molecular test methods

LGC expedites access to its core technology to support a rapid response to the coronavirus global health emergency

News (ZH) - Supporting efforts to contain virus by expediting availability of mission-critical oligo chemistries, controls and components

Arbor Biosciences and LGC, Biosearch Technologies partner on marker discovery and genotyping in agrigenomics

News (ZH) - Biosearch Technologies becomes exclusive global provider of custom hybridization-based targeted sequencing oligonucleotide panels

LGC acquires C/D/N Isotopes

News (ZH) - Acquisition of CDN strengthens LGC’s position in the deuterated compound market

LGC custom oligonucleotides used to develop innovative arboviruses diagnostic kit

News (ZH) - Innovative kit,  recently registered with the National Health Surveillance Agency, can screen for differentiation in the same reaction on the type of dengue (1, 2, 3 or 4)